Table
of Contents
|
|
|
|
List of
contributors |
viii |
|
Foreword |
xiii |
|
Introduction |
xvii |
PART 1 |
EPIDEMIOLOGY OF KIDNEY DISEASE |
1 |
1 |
Kpidemiology of Chronic Kidney
Disease William M. McClellan & Friedrich K. Port |
3 |
2 |
Chronic
Disease Surveillance and Chronic Kidney Disease Diane L. Frankenfield
& Michael V. Rocco |
18 |
3 |
Risk Factors
for Progression of Chronic Kidney Disease Eberhard
Ritz, Danilo
Fliser,
& Marcin
Adamczak |
29 |
4 |
Epidemiology
and Screening for Chronic Kidney Disease Sylvia Paz B.
Ramirez |
43 |
5 |
Prediction
of Risk and Prognosis: Decision Support for Diagnosis and Management of
Chronic Kidney Disease Benedicts Stengel, Marc Froissart, & Jerome Rossert |
58 |
PART 2 |
ACUTE KIDNEY INJURY |
69 |
6 |
Definition,
Classification, and Epidemiology of Acule Kidney
Disease Eric A.J, Hoste, Ramesh Venkataraman, & John A. Kellum 71 |
|
7 |
Pre-Renal
Failure and Obstructive Disease Kevin W. Frankel |
80 |
8 |
Hepatorenal
Syndrome Andrés Cardenas & Pere Ginès 88 |
|
9 |
Acute
Tubular Necrosis Jay L. Koyner & Patrick T. Murray |
97 |
10 |
Radiocontrast
Nephropathy Brendan J. Barrett & Patrick S. Parfrey |
110 |
11 |
Miscellaneous
Etiologies of Acute Kidney Injury Kamalanathan K. Sambandam & Anitha Vijayan |
122 |
12 |
Renal
Replacement Therapy in Acute Kidney Injury Steven IX Weisbord &
Paul M. Palevsky |
137 |
PART 3 |
PRIMARY GLOMERULONEPHRITIS |
147 |
13 |
Management
of Idiopathic Nephrotic
Syndrome in Adults: Minimal Change Disease and Focal Segmental Glomerulosclerosis Alain
Meyrier |
149 |
14 |
Membranous
Nephropathy Fernando C. Fervenza & Daniel C. Cattran |
158 |
15 |
IgA Nephropathy in Adults and
Children Jonathan Barratt, John Feehally, & Ronald Hogg |
170 |
16 |
Membranoproliferative Glomerulonephritis Richard
J. Glassock |
183 |
PART 4 |
SECONDARY DISEASES OF THE
KIDNEY |
197 |
|
Hypertensive Renal Disease |
199 |
17 |
Hypertension:
Classification and Diagnosis Bernardo Rodriguez-Iturbe 6- Crispín Mann
Villalobos 200 |
|
18 |
Management
of Essential Hypertension Eberhard Ritz, Danilo Fliser, &
Martin Adamczak |
207 |
19 |
Management
of Hypertension in Chronic Kidney Disease Aimun
Ahmed, Fairol
H. Ibrahim,
& Meguid
El Nahas
214 |
|
20 |
Diagnosis
and Management of Renovascular
Disease Jö’rg
Radermacher |
223 |
21 |
Diabetes
Mellitus Piero Ruggenenti & Giuseppe Remuzzi |
231 |
22 |
Lupus
Nephritis Arrigo Schieppati, Erica Daina, &
Giuseppe Remuzzi |
244 |
23 |
Infection-Related
Nephropathies Monique E. Cho & Jeffrey B. Kopp |
253 |
24 |
Hepatitis B
Virus M Aamir
Ali, Scott D. Cohen, & Paul L Kimmel |
263 |
25 |
Infection-Related
Nephropathies: Hepatitis C Virus Dirk R.J. Kuypers |
272 |
26 |
Polyomavirus-Associated
Nephropathy Fabrizio Ginevri & Hans H. Hirsch |
277 |
|
Toxic Nephropathies |
285 |
27 |
Toxic
Nephropathies: Nonsteroidal
Anti-Inflammatory Drugs Wai Y. Tse & Dwomoa Ada |
286 |
28 |
Toxic Nephropathies:
Environmental Agents and Metals Richard P. Wedeen |
294 |
29 |
The Kidney
in Pregnancy Phyllis August & Tiina Podymow |
299 |
PART 5 |
CHRONIC KIDNEY DISEASE, CHRONIC RENAL
FAILURE |
309 |
30 |
Progression of
Kidney Disease: Diagnosis and Management Anil K. Agarwal, Nabil Haddad,
& Lee A. Hebert |
311 |
31 |
Treatment of
Anemia in Chronic Kidney Disease, Stages 3-5 Robert N,
Foley |
323 |
32 |
Dyslipidcmia in Chronic Kidney
Disease Vera Krane & Christoph Wanner |
333 |
33 |
Chronic
Kidney Disease and Hypertension Sangeetha Satyan & Rajiv Agarwal |
345 |
34 |
Recognition
and Management of Mineral and Bone Disorder of Chronic Kidney Disease and
End-Stage Renal Disease Donald A. Molony |
353 |
35 |
Preparation tor
Dialysis Mark G. Parker & Jonathan Himmelfarb |
391 |
PART 6 |
CHRONIC KIDNEY DISEASE STAGE 5:
HEMODIALYSIS |
401 |
36 |
When to
Start Dialysis and Whether the First Treatment Should Be Extracorporeal Therapy
or Peritoneal Dialysis Raymond T. Krediet |
403 |
37 |
Modalities
of Extracorporeai
Therapy: Hemodialysis,
Hemofiltration,
and Hemodiafiltration Kannaiyan
S. Rabindranath
& Norman Muirhead |
410 |
38 |
Dialysis
Delivery and Adequacy Peter Kotanko, Nathan W. Levin, &
Frank Gotch423 |
|
39 |
General
Management of the Hemodialysis
Patient Robert Mactier & David C. Wheeler |
431 |
40 |
Infections
in Hemodialysis Behdad
Afzali
& David J. A. Goldsmith |
441 |
41 |
Non-Access-Related
Nosocomial
Infections in Hemodialysis Brett
W. Stephens & Donald A. Molony |
452 |
42 |
Vascular
Access for Hemodialysis Kevan
R. Polkinghorne |
460 |
PART 7 |
CHRONIC KIDNEY DISEASE STAGE 5:
PERITONEAL DIALYSIS |
469 |
43 |
Selection of
Peritoneal Dialysis as Renal Replacement Therapy Norbert Lameire, Raymond
Vanholder,
& Wim
Van Biesen |
471 |
44 |
Small Solute
Clearance in Peritoneal Dialysis Sharon J. Nessim &
Joanne M. Bargman |
478 |
45 |
Salt and Water
Balance in Peritoneal Dialysis Cheuk-Chun Szeto &
Philip Kam-Tao
Li |
488 |
46 |
Impact of
Peritoneal Dialysis Solutions on Outcomes David W.
Johnson & John D. Williams 500 |
|
47 |
Prevention and
Treatment of Peritoneal Dialysis-Related Infections Giovanni
F. M. Sirippoli,
Kathryn J. Wiggins, David W. Johnson, Sankar Navaneethan, Giovanni Gancarini, &
Jonathan C. Craig |
509 |
PART 8 |
TRANSPLANTATION |
533 |
48 |
Evaluation and
Selection of the Kidney Transplant Candidate Bryce Kiberd |
535 |
49 |
Evaluation
and Selection of the Living Kidney Donor Connie L. Davis |
545 |
50 |
Predictors
of Transplant Outcomes Krista L. Lentine, Robert M. Perkins, &
Kevin C. Abbott |
561 |
51 |
The Early
Course: Induction, Delayed Function, and Rejection Paul
A. Keown |
574 |
52 |
Maintenance Imrrmnosupprcssion Yves
Vanrenterghem |
592 |
53 |
Chronic
Allograft Nephropathy Bengt C. Fellström, Alan Jardine:, & Hallvard Holdaas |
599 |
PART 9 |
DISORDERS OF ELECTROLYTES
(ACUTE AND CHRONIC) |
609 |
54 |
Overview of
Electrolyte and Acid-Base Disorders L. Lee Hamm &
Michael Hadcrlie |
611 |
55 |
Hyponatremia Chuiwuma
Eze &
Eric E. Simon |
618 |
56 |
Potassium
Disorders John R. Foringer, Christopher Morris, &
Kevin W. Finkel |
633 |
57 |
Metabolic
Evaluation and Prevention of Renal Stone Disease David S.
Goldfarb |
642 |
PART 10 |
PEDIATRICS |
651 |
|
Themes Across Renal Disease and Renal Failure |
653 |
58 |
Growth,
Nutrition, and Pubertal Development Lesley Rees |
654 |
59 |
Hypertension,
Cardiovascular Disease, and Lipid Abnormalities in Children with Chronic
Kidney Failure Elke Wühl & Franz Schaefer |
669 |
60 |
Bones Across
Kidney Disease and Kidney Failure Mary B. Leonard |
682 |
61 |
Anemia Susan
Furth
& Sandra Amaral |
693 |
|
Management of Renal Failure/Transplants |
702 |
62 |
Renal
Transplantation Pierre Cochat & Justine Bacchetta |
703 |
63 |
Peritoneal Dialysis
in Children Jaap W. Groothoff & Maruschka P. Merkus |
723 |
64 |
Pediatric Hemodialysis Stuart
L. Goldstein |
738 |
|
Specific Pediatric Renal Disease |
745 |
65 |
Urinary
Tract Infection, Vesicoureteric
Reflux, and Urinary Incontinence Gabrielle Williams, Premala Sureshkumar, Patrina Caldwelh &
Jonathan C. Craig |
746 |
66 |
Epidemiology
and General Management of Childhood ldiopathic Nephrotic
Syndrome Nicholas j. A. Webb |
763 |
67 |
Management
of Steroid-Sensitive Nephrotic
Syndrome Elisabeth M. Hodson, Jonathan C. Craig, & Narelle S. Willis |
774 |
68 |
Steroid-Resistant
Nephrotic
Syndrome Annabelle Chua & Peter Yorgin |
787 |
|
Other Pediatric Renal Diseases |
806 |
69 |
Henoch-Schonlein Nephritis and Membranoprolifertive
Glomerulonephntis Sharon
Phillips Andreoli |
807 |
70 |
Cystinosis William
G. van’t
Hoff |
818 |
|
Index |
823 |
|
|
|